CITALOPRAM
- Product NDC
- 59651-964
- 11-digit product format
- 596510964
- Labeler code
- 59651
- Product ID
- 59651-964_80af8ae8-c106-4895-bab3-0579b41f1e75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CITALOPRAM
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA219985
- Marketing category
- ANDA
- Marketing start
- 2026-03-13
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| I1E9D14F36 | CITALOPRAM HYDROBROMIDE | 59729-32-7 | CITALOPRAM HYDROBROMIDE |
| 0DHU5B8D6V | CITALOPRAM | 59729-33-8 | CITALOPRAM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 59651-964-30 | 59651096430 | 30 CAPSULE in 1 BOTTLE (59651-964-30) | 30 capsule | 2026-03-13 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| CITALOPRAM | Aurobindo Pharma Limited | 2026-03-18 | Human Prescription Drug Label | 1 |